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Although several techniques have been used for the characterization of ex vivo calcium 
pyrophosphate (CPP: Ca2P2O7·nH2O) deposits associated to osteoarthritis,little is known from 
a chemical point of view on these phases which are difficult to synthesize, could evolve 
during their formation in vivo and be altered after extraction during conservation, preparation 
and analysis. Recently, Gras et al.established a protocol allowing a one-step and fast synthesis 
of four phases of CPP of biological interest by monitoring the pH and temperature during the 
synthesis.The stability and evolution properties of these synthetic phases have been 
investigated and ex vivo specimen analyses were conducted on cryoground meniscii and 
synovial fluid specimens of arthritic patients to avoid any alteration of the samples. 
Synchrotron X-ray diffraction and Raman spectroscopy were used to analyse synthetic 
samples, including monoclinic and triclinic calcium pyrophosphate dihydrate (m-CPPD and t-
CPPD: Ca2P2O7·2H2O), the two phases detected in joints of arthritic patients, and ex 
vivobiological samples. This studyhighlights the good selectivity of these techniques to detect 
both of the CPPD phases in complex media such as meniscus and synovial fluid, and to 
determine their ratio. In accordance with their thermodynamic stability, the data suggests the 
evolution of CPP in vivo from m-CPPD to t-CPPD. Although precursor phases could be 
involved their identification seems yet difficult. Progresses in the fine characterization of the 
different synthetic CPP phases could improve their detection in patients suffering from 
calcium-salt crystal diseases and could contribute to clarifying the mechanism by which CPP 
crystals form and evolve in vivo. 
 
 
